制药公司敦促欧盟削减繁琐手续,警告投资100B欧元可能会转移到美国。 Pharma firms urge EU to cut red tape, warning €100B in investments may move to the U.S.

制药公司敦促欧盟减轻监管负担和简化政策,并担心由于监管压力加大和预期的美国关税,今后多达1000亿欧元的投资可能离开欧洲。 Pharmaceutical companies are urging the EU to ease regulatory burdens and simplify policies, citing concerns that up to €100 billion in future investments could leave Europe due to increased regulatory pressure and anticipated US tariffs. 这些公司警告说,如果没有变化,它们可能会转移到美国,因为美国毒品价格要高得多。 The companies warn that without changes, they may relocate to the US, where drug prices are significantly higher. 联合王国还面临美国关税的潜在损害,工业领导人游说免征豁免,以避免巨大的金融影响和潜在的短缺。 The UK also faces potential damage from US tariffs, with industry leaders lobbying for exemptions to avoid significant financial impacts and potential shortages.